FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Arthur Klausner will participate on a panel at the Biotechnology Entrepreneurship Boot Camp program that is associated with the the BIO International Convention in San Diego, CA
News | 06. 17. 2008
